Tadalafil-Xantis Xantis Pharma — Research Summary
Tadalafil-Xantis is a phosphodiesterase type 5 (PDE5) inhibitor compound manufactured by Xantis Pharma for in-vitro laboratory research applications. This selective enzyme inhibitor demonstrates high specificity for PDE5 compared to other phosphodiesterase isoforms, making it a valuable research tool for investigating cyclic guanosine monophosphate (cGMP) signalling pathways. Researchers studying cardiovascular physiology, smooth muscle function, and nitric oxide-dependent mechanisms frequently utilise this compound in controlled laboratory environments. The compound’s well-characterised pharmacological profile enables precise investigation of PDE5-mediated cellular processes across various experimental models.
Laboratory Applications
Research scientists examine Tadalafil-Xantis to investigate PDE5 inhibition mechanisms in cardiovascular tissue studies and smooth muscle cell biology. The compound’s selectivity profile allows researchers to study cGMP pathway modulation without significant interference from other phosphodiesterase enzymes. Laboratories exploring nitric oxide signalling, endothelial function, and vascular smooth muscle contractility benefit from this compound’s consistent inhibitory activity. Comparative studies often utilise Tadalafil-Xantis alongside other PDE inhibitors to evaluate selectivity profiles and potency differences. Cell culture experiments examining smooth muscle relaxation mechanisms frequently incorporate this compound to understand PDE5-dependent pathways. Researchers at Stroid UK Shop can access this compound for comprehensive phosphodiesterase research programmes. The compound complements other research chemicals available in our tadalafil research collection, alongside popular compounds like those found in our SARM research portfolio and peptide research library.
Technical Specifications
| Parameter | Value |
|---|---|
| Chemical Name | Verify with supplier |
| CAS Number | Verify with supplier |
| Molecular Formula | Verify with supplier |
| Molecular Weight | Verify with supplier |
| Manufacturer | Xantis Pharma |
| Storage Conditions | Room temperature, dry environment |
| Research Applications | PDE5 inhibition studies, cardiovascular research |
Research Compliance Statement
Tadalafil-Xantis from Xantis Pharma is intended exclusively for in-vitro laboratory research purposes and is not approved for human consumption, clinical use, or any therapeutic applications. This research chemical must be handled by qualified laboratory personnel in appropriate research facilities with proper safety protocols. Researchers must comply with all applicable laboratory safety regulations and institutional guidelines when studying this compound.
